PK, Safety & Tolerability of CyCol® Versus Sandimmune® in Healthy Subjects
NCT02130414
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
48
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
Sandimmun® IV
DRUG:
CyCol® capsules
Sponsor
Sigmoid Pharma